Possible Consequences for the Pharma Industry if the USP Revision of the General Chapters 41 and 1251 is Enacted
Add bookmarkPossible Consequences for the Pharma Industry if the USP Revision of the General Chapters 41 and 1251 is Enacted
Add bookmark
Expected for a long time, USP has published a new draft to revise the General Chapters 41 “Balances” and 1251 “Weighing on an Analytical Balance” in the Pharmacopeial Forum PF 38(5) on September 4, 2012. One consequence of General Chapter 41 is the so-called minimum weight, which needs to be adhered to in order to fulfill applicable accuracy requirements for weighing systems.
It is very important to understand that the concept of minimum weight is not only restricted to applications in the scope of USP General Chapter 41, but applies to any weighing instrument - for balances in the laboratory and for scales in the production area.
In this podcast, learn from the GWP® weighing experts of METTLER TOLEDO and a USP expert panel member what the possible consequences for the pharmaceutical Industry are and what can be done to be prepared in an optimal way.
Listen to this brief podcast to:
- Understand the consequences of possible changes of the USP revision of the General Chapters 41 and 1251
- Learn how you can prepare yourself proactively
- Hear what a possible solution might be
For more information, download our recently published GWP® White Paper to:
- Understand the concept of minimum weight as the key to ensure consistently accurate weighing results in the laboratory and the production area
- Learn how your specific weighing process requirements can be fulfilled and documented by a scientific strategy to select, calibrate and test your weighing systems
- Get insights into the risk-based approach to performing routine testing of balances and scales
- Learn about the proper weight selection for routine testing of balances and scales
Join our presentation about GWP® at the ISPE Annual Meeting on November 11 – 14, 2012, during session 206 "Innovation in Laboratory and Production Operations“. For further information, visit
http://www.ispe.org/2012-annual-meeting/innovation-laboratory-operations.
|
|
Have Your Say Rate this feature and give us your feedback in the comments section below |